Sodium intake and multiple sclerosis activity and progression in BENEFIT by Fitzgerald, Kathryn C., Munger, Kassandra L., Hartung, Hans‐Peter, Freedman, Mark S., Montalbán, Xavier, Edan, Gilles, Wicklein, Eva‐Maria, Radue, Ernst‐Wilhelm, Kappos, Ludwig, Pohl, Christoph, Ascherio, Alberto, Strasser‐Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Štourač, P, Talab, R, Zapletalova, O, Kovařova, I, Medova, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun‐Frenay, C, Gout, O, Kallela, M, Pirttila, T, Ruutiainen, J, Koivisto, K, Villringer, A, Altenkirch, H, Wessel, K, Hartung, H‐P, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoffmann, F, Baum, K, Jung, S, Petereit, H, Reske, D, Sailer, M, Kohler, J, Sommer, N, Hohlfeld, R, Gold, R, Rieckmann, P, Komoly, R, Jakab, G, Csiba, L, Vecsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Cosi, V, Anten, B, Myhr, K‐M, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega‐Jazbec, S, Montalban, X, Arbizu, T, Saiz, A, Barcena, J, Arroyo, R, Fernandez, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, Riordan, J O, Howell, S

Get full text

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study by Kappos, Ludwig, Prof, Gold, Ralf, Prof, Miller, David H, Prof, MacManus, David G, MSc, Havrdova, Eva, MD, Limmroth, Volker, MD, Polman, Chris H, Prof, Schmierer, Klaus, PhD, Yousry, Tarek A, MD, Yang, Minhua, MS, Eraksoy, Mefkûre, Prof, Meluzinova, Eva, MD, Rektor, Ivan, MD, Dawson, Katherine T, MD, Sandrock, Alfred W, MD, O'Neill, Gilmore N, MB

Get full text

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT... by Kappos, Ludwig, MD, Freedman, Mark S, MD, Polman, Chris H, MD, Edan, Gilles, MD, Hartung, Hans-Peter, MD, Miller, David H, MD, Montalbán, Xavier, MD, Barkhof, Frederik, MD, Radü, Ernst-Wilhelm, MD, Metzig, Carola, MD, Bauer, Lars, MD, Lanius, Vivian, PhD, Sandbrink, Rupert, MD, Pohl, Christoph, MD

Get full text

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase II... by Comi, G, Prof, Pulizzi, A, MD, Rovaris, M, MD, Abramsky, O, Prof, Arbizu, T, MD, Boiko, A, Prof, Gold, R, Prof, Havrdova, E, Prof, Komoly, S, Prof, Selmaj, KW, Prof, Sharrack, B, MD, Filippi, M, MD

Get full text

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo... by Comi, G., Abramsky, O, Arbizu, T, Boyko, A, Gold, R, Havrdová, E, Komoly, S, Selmaj, K, Sharrack, B, Filippi, M

Get full text

Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b by Polman, C., Kappos, L., Freedman, M. S., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Selmaj, K., Uitdehaag, B. M. J., Dahms, S., Bauer, L., Pohl, C., Sandbrink, R.

Get full text

4-31-14 Isoprinosine in multiple sclerosis treatment by Maciejek, Z., Niezgodzińska-Maciejek, A.

Get full text

Red blood cell glutathione peroxidase activity in multiple sclerosis by Zachara, B., Gromadzińska, J., Czernicki, J., Maciejek, Ź., Chmielewski, H.

Get full text